These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 22695844)
1. Lactosylceramide synthase as a therapeutic target to mitigate multiple human diseases in animal models. Chatterjee S; Alsaeedi N Adv Exp Med Biol; 2012; 749():153-69. PubMed ID: 22695844 [No Abstract] [Full Text] [Related]
2. Concise syntheses of selective inhibitors against α-1,3-galactosyltransferase. Zhang GL; Zhang LH; Ye XS Org Biomol Chem; 2010 Nov; 8(22):5062-8. PubMed ID: 20820649 [TBL] [Abstract][Full Text] [Related]
3. A new concept for glycosyltransferase inhibitors: nonionic mimics of the nucleotide donor of the human blood group B galactosyltransferase. Schaefer K; Albers J; Sindhuwinata N; Peters T; Meyer B Chembiochem; 2012 Feb; 13(3):443-50. PubMed ID: 22223604 [TBL] [Abstract][Full Text] [Related]
4. A novel, promoter-based, target-specific assay identifies 2-deoxy-D-glucose as an inhibitor of globotriaosylceramide biosynthesis. Okuda T; Furukawa K; Nakayama K FEBS J; 2009 Sep; 276(18):5191-202. PubMed ID: 19674101 [TBL] [Abstract][Full Text] [Related]
5. Acceptor substrate-based selective inhibition of galactosyltransferases. Chung SJ; Takayama S; Wong CH Bioorg Med Chem Lett; 1998 Dec; 8(23):3359-64. PubMed ID: 9873734 [TBL] [Abstract][Full Text] [Related]
6. Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus. Veldman RJ; Klappe K; Hinrichs J; Hummel I; van der Schaaf G; Sietsma H; Kok JW FASEB J; 2002 Jul; 16(9):1111-3. PubMed ID: 12039850 [TBL] [Abstract][Full Text] [Related]
7. Screening for inhibitors of chloroplast galactolipid synthesis acting in membrano and in planta. Boudière L; Maréchal E Methods Mol Biol; 2014; 1056():79-93. PubMed ID: 24306864 [TBL] [Abstract][Full Text] [Related]
8. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes. Dabroś W; Kordowiak AM; Dziga D; Gryboś R Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409 [TBL] [Abstract][Full Text] [Related]
9. β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. Tokuda N; Numata S; Li X; Nomura T; Takizawa M; Kondo Y; Yamashita Y; Hashimoto N; Kiyono T; Urano T; Furukawa K; Furukawa K Glycobiology; 2013 Oct; 23(10):1175-83. PubMed ID: 23882130 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new inhibitors of UDP-Galf transferase--a key enzyme in M. tuberculosis cell wall biosynthesis. Cren S; Gurcha SS; Blake AJ; Besra GS; Thomas NR Org Biomol Chem; 2004 Sep; 2(17):2418-20. PubMed ID: 15326520 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2-deoxy-hexopyranosyl derivatives of uridine as donor substrate analogues for glycosyltransferases. Wandzik I; Bieg T; Czaplicka M Bioorg Chem; 2009 Dec; 37(6):211-6. PubMed ID: 19765794 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 5'-glycyl derivatives of uridine as inhibitors of 1,4-β-galactosyltransferase. Paszkowska J; Kral K; Bieg T; Żaba K; Węgrzyk K; Jaśkowiak N; Molinaro A; Silipo A; Wandzik I Bioorg Chem; 2015 Feb; 58():18-25. PubMed ID: 25462623 [TBL] [Abstract][Full Text] [Related]
13. Enzymatic characterization of UDP-galactose:FdSdG galactosyltransferase in purified liver plasma membrane. Fernandez-Briera A; Louisot P; Morelis R Biochem Int; 1989 Feb; 18(2):415-28. PubMed ID: 2504163 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of lactosylceramide synthase in MDR1 overexpressing human liver tumour cells. Hummel I; Klappe K; Kok JW FEBS Lett; 2005 Jun; 579(16):3381-4. PubMed ID: 15936020 [TBL] [Abstract][Full Text] [Related]
15. Target-assisted selection of galactosyltransferase binders from dynamic combinatorial libraries. An unexpected solution with restricted amounts of the enzyme. Valade A; Urban D; Beau JM Chembiochem; 2006 Jul; 7(7):1023-7. PubMed ID: 16715540 [No Abstract] [Full Text] [Related]
16. Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Nishie T; Hikimochi Y; Zama K; Fukusumi Y; Ito M; Yokoyama H; Naruse C; Ito M; Asano M Glycobiology; 2010 Oct; 20(10):1311-22. PubMed ID: 20574042 [TBL] [Abstract][Full Text] [Related]
17. Oxidized low density lipoproteins and lactosylceramide both stimulate the expression of proliferating cell nuclear antigen and the proliferation of aortic smooth muscle cells. Chatterjee S Indian J Biochem Biophys; 1997; 34(1-2):56-60. PubMed ID: 9343929 [TBL] [Abstract][Full Text] [Related]
18. A nonionic inhibitor with high specificity for the UDP-Gal donor binding site of human blood group B galactosyltransferase: design, synthesis, and characterization. Schaefer K; Sindhuwinata N; Hackl T; Kötzler MP; Niemeyer FC; Palcic MM; Peters T; Meyer B J Med Chem; 2013 Mar; 56(5):2150-4. PubMed ID: 23406460 [TBL] [Abstract][Full Text] [Related]
19. Effects of ATP on regulation of galactosyltransferase-I activity responsible for synthesis of the linkage region between the core protein and glycosaminoglycan chains of proteoglycans. Higuchi T; Tamura S; Tanaka K; Takagaki K; Saito Y; Endo M Biochem Cell Biol; 2001; 79(2):159-64. PubMed ID: 11310563 [TBL] [Abstract][Full Text] [Related]
20. [Glycosyltransferase inhibitors and study of UDP-galactose-globoside galactosyltransferase]. McCluer R; Koul O Biokhimiia; 1995 Mar; 60(3):419-31. PubMed ID: 7734615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]